Sanofi India cash flow

Latest FY26

Cash from operations: ₹438cr−5.1% on FY25
Capital spending: ₹25.7cr−29.4% on FY25
Free cash flow: ₹413cr−3.0% on FY25
Cash from financing: −₹448cr−₹552 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Dec 2025	FY25Dec 2024	FY24Dec 2023	FY23Dec 2022	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	37.3	38.2	39.6	41.9
	—	1.7	1.5	1.7	1.7
	—	−14.0	−16.6	−47.5	−58.9
	—	2.4	1.2	6.1	2.1
	—	1.4	0.6	−0.4	2.3
	—	−1.3	0.7	−1.2	1.5
	—	1.3	−0.5	−23.1	−150
	—	0.0	131	0.0	0.0
	—	188	68.7	−256	−31.4
	—	53.1	−127	0.6	20.6
	—	41.5	−35.7	−0.7	−4.3
	—	5.7	−2.1	4.0	1.0
	—	22.3	−89.8	10.1	−2.4
	—	0.1	−0.7	0.1	0.0
	—	−215	166	−66.9	−28.0
	—	−15.9	13.4	4.0	1.5
	—	−6.5	−7.3	−17.5	16.6
	—	−2.0	−14.3	−26.8	−19.2
Cash from operating activities
	491	445	431	846	864
	—	100	128	−374	−205
	—	545	559	472	659
	—	107	97.4	241	261
	—	438	462	231	399
Cash from investing activities
	—	25.7	36.4	34.3	22.2
	—	0.4	0.0	0.0	3.3
	—	0.0	0.0	2.0	0.0
	—	0.0	0.0	0.0	445
	—	14.0	16.6	47.5	58.9
	—	0.0	0.6	24.3	166
	—	−11.3	−19.2	35.5	651
Cash from financing activities
	—	4.3	7.8	10.0	9.7
	—	1.4	0.0	0.0	0.0
	—	442	385	868	1,573
	—	0.0	−159	0.0	0.0
	—	−448	−552	−878	−1,583
	—	−20.9	−109	−612	−533
	—	−20.9	−109	−612	−533
	—	—	284	393	1,005
Reference items
	510	491	491	804	704
	28.0%	26.7%	24.4%	28.2%	25.4%
	413	413	425	197	377
	—	411	—	—	—
	₹179.39	₹179.39	₹184.91	₹85.43	₹163.70
	16.68×	—	—	—	—
	—	1.34×	1.12×	0.38×	0.64×
	—	107	97.4	241	261
	—	1.4	—	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SANOFI₹2,992.00

Sanofi India Limited

· Pharma & Health

₹ CrorePeersSENORES INNOVACAP PGHL MOREPENLAB IOLCP SANOFICONR FDC ORCHPHARMAMcap ₹6,882 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/12/2022	FY24 31/12/2023	FY25 31/12/2024	FY26 31/12/2025	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	41.9	39.6	38.2	37.3	—
+ Finance Costs	1.7	1.7	1.5	1.7	—
+ Interest Income	-58.9	-47.5	-16.6	-14.0	—
+ Share-based Payments	2.1	6.1	1.2	2.4	—
+ Unrealised FX (Gain) / Loss	2.3	-0.4	0.6	1.4	—
+ Other Non-cash Items	1.5	-1.2	0.7	-1.3	—
+ Other — Cash Effects are Investing / Financing	-149.9	-23.1	-0.5	1.3	—
+ Other Reconciling Items	0.0	0.0	131.2	0.0	—
Changes in Working Capital
+ Inventories	-31.4	-255.8	68.7	188.2	—
+ Trade Receivables — Current	20.6	0.6	-127.0	53.1	—
+ Other Financial Assets — Current	-4.3	-0.7	-35.7	41.5	—
+ Other Financial Assets — Non-current	1.0	4.0	-2.1	5.7	—
+ Other Current Assets	-2.4	10.1	-89.8	22.3	—
+ Other Non-current Assets	0.0	0.1	-0.7	0.1	—
+ Trade Payables — Current	-28.0	-66.9	166.2	-214.9	—
+ Other Financial Liabilities — Current	1.5	4.0	13.4	-15.9	—
+ Other Current Liabilities	16.6	-17.5	-7.3	-6.5	—
+ Provisions — Current	-19.2	-26.8	-14.3	-2.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	864.3	845.8	431.4	444.7	490.9
+ Total Adjustments (incl. Working Capital)	-204.9	-373.7	127.7	100.4	—
Cash from Operations (pre-tax)	659.4	472.1	559.1	545.1	—
+ Income Taxes Paid	260.7	241.3	97.4	106.8	—
Cash from Operating Activities	398.7	230.8	461.7	438.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	22.2	34.3	36.4	25.7	—
+ Disp of Fixed Assets	3.3	0.0	0.0	0.4	—
+ Acq of Subsidiaries / Businesses (net)	0.0	2.0	0.0	0.0	—
+ Loans & Advances Repaid	445.0	0.0	0.0	0.0	—
+ Interest Received — Investing	58.9	47.5	16.6	14.0	—
+ Other Inflows / (Outflows) — Investing	165.9	24.3	0.6	0.0	—
Cash from Investing Activities	650.9	35.5	-19.2	-11.3	—
Cash from Financing Activities
+ Payment of Lease Liabilities	9.7	10.0	7.8	4.3	—
+ Interest Paid	0.0	0.0	0.0	1.4	—
+ Dividends Paid	1,573.0	868.3	384.6	442.2	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	-159.2	0.0	—
Cash from Financing Activities	-1,582.7	-878.3	-551.6	-447.9	—
Net Changes in Cash (pre-FX)	-533.1	-612.0	-109.1	-20.9	—
Net Changes in Cash	-533.1	-612.0	-109.1	-20.9	—
Closing Cash	1,004.9	392.9	283.8	—	—
Reference Items
EBITDA	704.4	804.0	490.8	491.3	509.6
EBITDA Margin %	25.43	28.20	24.38	26.74	27.98
Free Cash Flow (CFO − Capex)	376.5	196.5	425.3	412.6	412.6
Free Cash Flow to Equity	—	—	—	411.2	—
Free Cash Flow per Basic Share	163.70	85.43	184.91	179.39	179.39
Price to Free Cash Flow	—	—	—	—	16.68
Cash Flow to Net Income	0.64	0.38	1.12	1.34	—
Cash Paid for Taxes	260.7	241.3	97.4	106.8	—
Cash Paid for Interest	—	—	—	1.4	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.